Editing Gout (section)

==Research==
A number of new medications are under study for treating gout, including [[anakinra]], [[canakinumab]], and [[rilonacept]].<ref>{{cite journal |url=http://www.musculoskeletalnetwork.com/gout/content/article/1145622/1533314 |title=New therapeutic options for gout here and on the horizon |journal=Journal of Musculoskeletal Medicine |date=8 March 2010 |author1=Abeles, A. M. |author2=Pillinger, M. H. |url-status=dead |archive-url=https://web.archive.org/web/20100520024113/http://www.musculoskeletalnetwork.com/gout/content/article/1145622/1533314 |archive-date=20 May 2010 |access-date=23 April 2010 }}</ref> Canakinumab may result in better outcomes than a low dose of a glucocorticoid, but costs five thousand times more.<ref>{{cite journal|last1=Sivera|first1=F|last2=Wechalekar|first2=MD|last3=Andrés|first3=M|last4=Buchbinder|first4=R|last5=Carmona|first5=L|title=Interleukin-1 inhibitors for acute gout|journal=The Cochrane Database of Systematic Reviews|date=1 September 2014|volume=2014|issue=9|pages=CD009993|pmid=25177840|doi=10.1002/14651858.CD009993.pub2|pmc=10891421}}</ref> A [[Recombinant DNA|recombinant]] [[uricase]] enzyme ([[rasburicase]]) is available but its use is limited, as it triggers an [[immune]] response. Less [[antigenic]] versions are in development.<ref name=Egg2007/>